Valery V. Shipitsyn
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: May 14, 2026
CYP3A4*22 and CYP3A5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome.
Journal: Nordic journal of psychiatry
Published: April 26, 2022
Effects of CYP2C19*17 genetic polymorphisms on plasma and saliva concentrations of diazepam in patients with alcohol withdrawal syndrome.
Journal: Psychiatric genetics
Published: January 10, 2022
Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome.
Journal: Hospital pharmacy
Published: November 01, 2021
Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders.
Journal: Journal of psychiatric practice
Published: September 16, 2021
Using the CYP3A Activity Evaluation to Predict the Efficacy and Safety of Diazepam in Patients With Alcohol Withdrawal Syndrome.
Journal: Journal of pharmacy practice
Published: February 24, 2021
Socio-economic aspects of neurogenic dysfunctions in urology
Journal: Urologiia (Moscow, Russia : 1999)
Published: November 13, 2020
Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder.
Journal: The pharmacogenomics journal
Published: June 01, 2020
ECONOMIC BURDEN AND CURRENT STATUS OF THE DRUG SUPPLY MANAGEMENT FOR IMMUNE INFLAMMATORY DISEASES (BY EXAMPLE OF ULCERATIVE COLITIS AND CROHN'S DISEASE)
Journal: Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny
Published: May 12, 2020
Using a pharmacogenetic clinical decision support system to improve psychopharmacotherapy dosing in patients with affective disorders.
Journal: Drug metabolism and personalized therapy
Published: January 09, 2020
How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome?
Journal: Drug metabolism and personalized therapy
Published: September 24, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026